Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AML
AML
FDA slaps a hold on an AML trial as Marker scraps a failing ovarian cancer program, sinking shares
Endpoints
Thu, 11/14/19 - 07:29 pm
Marker Therapeutics
AML
ovarian cancer
clinical trials
FDA
Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata
Pharmaforum
Sun, 09/22/19 - 11:02 pm
Astellas
AML
Xospata
Europe
Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Fri, 09/20/19 - 10:40 pm
Astellas
FDA
gilteritinib
Europe
AML
Daiichi Sankyo
Roche and Celgene set for battle in acute myelogenous leukaemia
EP Vantage
Wed, 09/18/19 - 09:54 am
Celgene
Roche
AML
acute myeloid leukemia
CC-486
Venclexta
Celgene's AML drug clears late-stage test
Endpoints
Mon, 09/16/19 - 09:17 am
Celgene
AML
CC-486
acute myeloid leukemia
Next up for GlycoMimetics after tanking in sickle cell disease
BioCentury
Mon, 08/5/19 - 10:32 pm
GlycoMimetics
AML
uproleselan
BerGenBio posts updated data on trial of elderly AML patients
Fierce Biotech
Fri, 06/14/19 - 10:12 am
BerGenBio
bemcentinib
AML
acute myeloid leukemia
AACR: Astellas pads Xospata's AML lead with chemo-beating survival data
Fierce Pharma
Mon, 04/1/19 - 12:38 pm
Astellas
Xospata
acute myeloid leukemia
AML
AACR
FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals
Endpoints
Thu, 11/29/18 - 12:10 am
Astellas
FDA
AML
Xospata
gilteritinib
AbbVie, Roche aim to face down Pfizer with Venclexta’s move into AML arena
Fierce Pharma
Mon, 11/26/18 - 12:35 pm
AbbVie
Venclexta
Roche
AML
Playing a hot hand in cancer R&D, Pfizer scores its 4th drug approval in just 2 months
Endpoints
Sat, 11/24/18 - 01:30 pm
Pfizer
FDA
glasdegib
acute myeloid leukemia
AML
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Sat, 11/24/18 - 01:27 pm
Roche
Genentech
Venclexta
FDA
AML
acute myeloid leukemia
Trovagene Receives Orphan Drug Designation for Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
CP Wire
Wed, 08/29/18 - 12:42 pm
TrovaGene
Onvansertib
AML
mCRPC
non-Hodgkin lymphoma
triple negative breast cancer
AbbVie, Tolero to collaborate on acute myeloid leukemia trial
Pharmaceutical Business Review
Mon, 08/20/18 - 10:44 pm
AbbVie
Tolero Pharmaceuticals
AML
venetoclax
alvocidib
Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches
Fierce Pharma
Mon, 08/20/18 - 11:46 am
Jazz Pharmaceuticals
hirings
drug reps
solriamfetol
narcolepsy
Europe
Vyxeos
AML
AbbVie, Tolero team up to test Venclexta combo in AML
Fierce Biotech
Sat, 08/18/18 - 05:09 pm
AbbVie
Tolero Pharmaceuticals
Venclexta
alvocidib
AML
Otsuka’s $886M-plus drug just flopped in its first crucial PhIII trial for frontline AML
Endpoints
Tue, 07/31/18 - 10:14 am
Otsuka
SGI-110
clinical trials
AML
Agios scores its second new drug approval, ivosidenib heads to the AML market
Endpoints
Fri, 07/20/18 - 11:52 am
Agios Pharmaceuticals
ivosidenib (AG-120)
AML
acute myeloid leukemia
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
CP Wire
Wed, 05/2/18 - 07:21 pm
Kura Oncology
tipifarnib
patents
AML
PTCL
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
CP Wire
Wed, 05/2/18 - 10:52 am
Aptevo
FDA
APVO436
AML
myelodysplastic syndrome
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »